Main distributor to Brazil and Latin America for analytical reference substances  |  Welcome! Olá! Hola! Español  |  +1.919.484.7555
You are here: Home /Europe /EMA consults on pharmacovigilance inspections, criteria for additional monitoring of drugs

EMA consults on pharmacovigilance inspections, criteria for additional monitoring of drugs

by JMC on July 6, 2012

The European Medicines Agency is seeking feedback on two new modules of the good pharmacovigilance practice (GVP) guideline1. The modules explain the requirements for pharmacovigilance inspections2 and the need for additional monitoring of certain drugs in the post-authorisation phase3

Previous post:

Next post: